🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the MycarinGstudy is to demonstrate the clinical efficacy an...
Status
Completed
Location
Mg0003 50081
Start Date
2019-06-03
Trial ID
NCT03971422
Treatments Being Tested
The purpose of this study is to demonstrate the clinical efficacy of rozano...
Status
Terminated
Location
Tp0003 50244
Start Date
2020-01-31
Trial ID
NCT04200456
Treatments Being Tested
The purpose of this study is to evaluate the ability of study participants ...
Status
Completed
Location
Mg0020 50092
Start Date
2023-04-17
Trial ID
NCT05681715
Treatments Being Tested
The purpose of the study is to assess the long term safety and tolerability...
Status
Enrolling By Invitation
Location
Mg0008 40290
Start Date
2024-10-08
Trial ID
NCT06540144
Treatments Being Tested
The purpose of the study is to assess the efficacy of rozanolixizumab as me...
Status
Terminated
Location
Aie001 50101
Start Date
2021-09-27
Trial ID
NCT04875975
Treatments Being Tested
The primary objective of the study is to check if an subcutaneous (sc) infu...
Status
Completed
Location
Tp0001 1101
Start Date
2016-03-02
Trial ID
NCT02718716
Treatments Being Tested
The purpose of the MycarinGstudy is to evaluate the long-term safety, toler...
Status
Completed
Location
Mg0004 50081
Start Date
2019-10-29
Trial ID
NCT04124965
Treatments Being Tested
The purpose of the study is to evaluate clinical efficacy of rozanolixizuma...
Status
Completed
Location
Cidp01 902
Start Date
2019-03-26
Trial ID
NCT03861481
Treatments Being Tested
Generalized Myasthenia Gravis (gMG) is a rare autoimmune disease (a disease...
Status
Recruiting
Location
CHU de NICE
Start Date
2026-06-15
Trial ID
NCT07570589
Treatments Being Tested
The purpose of the study is to evaluate the clinical efficacy of UCB7665 as...
Status
Completed
Location
Mg0002 712
Start Date
2017-05-15
Trial ID
NCT03052751